Loading field map
Every healthcare system faces a fundamental tension: how to organize care so that it is coordinated, high-quality, and financially sustainable. Over the past five decades, health services researchers have developed a series of frameworks that each offered a different answer to this question. These frameworks did not simply replace one another; they often coexisted, addressed different levels of the system, and eventually merged into broader approaches. Understanding their relationships—where they competed, where they complemented each other, and how earlier ideas persist within later ones—is essential for grasping how healthcare delivery is organized today.
Managed Care emerged in the 1970s as a direct response to rapidly rising healthcare costs under traditional fee-for-service payment. Its core logic was to place an insurer or health plan in the role of gatekeeper, using capitation payments, restricted provider networks, and utilization review to control spending. Health maintenance organizations (HMOs) became the emblematic form. Managed Care assumed that the main problem in healthcare delivery was overuse of expensive services driven by perverse financial incentives, and that the solution was to shift financial risk to providers and limit patient choice.
By the late 1980s, however, Managed Care faced a powerful backlash. Patients and physicians resented the restrictions on choice and the perception that cost containment came at the expense of quality. The framework’s narrow focus on payment mechanisms left it vulnerable to criticism that it ignored the clinical complexity of managing chronic illness and the organizational fragmentation that made coordination difficult. This dissatisfaction opened the door for frameworks that addressed care delivery itself rather than just financing.
The 1990s produced two influential frameworks that tackled different dimensions of the same problem. The Chronic Care Model (CCM), developed by Wagner and colleagues, shifted attention from acute, episodic care to the proactive management of chronic conditions. It provided a six-element blueprint—community resources, health system organization, self-management support, delivery system design, decision support, and clinical information systems—aimed at transforming primary care practices into settings where patients with chronic illnesses received planned, team-based care. CCM did not directly challenge Managed Care’s cost-containment goals; instead, it argued that better clinical management would itself reduce costly complications and hospitalizations.
At roughly the same time, the Integrated Delivery System (IDS) framework addressed a different level: the organizational structure of healthcare. IDS proponents argued that fragmentation—patients receiving care from multiple unconnected providers—was the root cause of poor quality and high costs. Their solution was vertical and horizontal integration: hospitals, physician groups, and other services would be brought under common ownership or tight contractual alignment to create seamless care pathways. Unlike Managed Care, which relied on insurer-driven rules, IDS placed the responsibility for coordination on provider organizations themselves.
These two frameworks coexisted as complementary rather than competing. CCM focused on what happened inside the clinical encounter; IDS focused on how organizations were structured to support those encounters. A well-integrated system could implement the Chronic Care Model more effectively, but integration alone did not guarantee that chronic care would be redesigned. The two frameworks together highlighted that both clinical process redesign and organizational restructuring were necessary for meaningful improvement.
The 2000s saw another pair of frameworks that operated at different levels while sharing common roots. The Patient-Centered Medical Home (PCMH) extended the Chronic Care Model’s principles into a comprehensive practice-level transformation. PCMH reimagined the primary care practice as a “medical home” where each patient had a personal physician, enhanced access (e.g., same-day appointments, after-hours care), care coordination, and team-based care. It introduced a new payment mechanism—a care coordination fee separate from visit-based reimbursement—to support activities that fee-for-service did not reward. PCMH was narrower in scope than CCM: it focused on primary care rather than the entire chronic care continuum, but it deepened the commitment to patient-centeredness and practice-level accountability.
At the population level, the Accountable Care Organization (ACO) framework emerged as a provider-led alternative to both Managed Care and IDS. An ACO is a group of providers who voluntarily assume collective responsibility for the quality and total cost of care for a defined patient population. Unlike IDS, which emphasized common ownership, ACOs could be formed through contractual agreements among independent providers. Unlike Managed Care, the financial risk was borne by providers rather than insurers, and savings were shared if quality targets were met. The Medicare Shared Savings Program, launched in 2012, became the most visible ACO model. ACOs and PCMHs were not rivals; they addressed different levels of the system. A PCMH could serve as the primary care foundation within an ACO’s population, and many ACOs encouraged their member practices to adopt PCMH principles.
Value-Based Care (VBC) is the dominant framework today, and it is best understood as an integrative approach that absorbs elements from all its predecessors rather than replacing them. VBC’s central premise is that healthcare should be organized and reimbursed according to the value it delivers—defined as outcomes achieved per dollar spent. This idea draws on Managed Care’s cost discipline but broadens it to include quality measurement and patient experience. It incorporates the Chronic Care Model’s emphasis on outcomes and proactive management, the Integrated Delivery System’s logic of coordination across settings, the Patient-Centered Medical Home’s focus on primary care redesign, and the Accountable Care Organization’s population-level accountability.
In practice, Value-Based Care operates through a family of alternative payment models: bundled payments for episodes of care, shared savings programs, capitation with quality bonuses, and pay-for-performance incentives. These models revive Managed Care’s capitation logic but embed it within a framework that rewards outcomes rather than simply limiting utilization. The Triple Aim—improving population health, enhancing patient experience, and reducing per capita cost—has become the guiding slogan for VBC initiatives.
Earlier frameworks have not disappeared; they persist as components within VBC. Managed Care’s gatekeeping and network design survive in narrow-network plans and prior authorization, though they are now justified as tools for steering patients to high-value providers. The Chronic Care Model’s elements are embedded in the quality measures and care management programs that VBC contracts require. Integrated Delivery Systems continue to exist, but the term has faded as the coordination logic has been absorbed into ACO and VBC structures. PCMH recognition programs remain active, often serving as a pathway for practices to qualify for value-based payments. ACOs are now one of the most common vehicles for implementing VBC.
Today, most researchers and policymakers agree that the fee-for-service payment model is unsustainable and that some form of value-based payment is necessary. There is broad consensus that outcomes measurement, care coordination, and population health management are essential components of a well-functioning delivery system. However, deep disagreements remain. How should “value” be defined and measured? Should it rely on clinical outcomes, patient-reported outcomes, or cost efficiency? How should risk adjustment work to avoid penalizing providers who care for sicker populations? There is also tension between population-level accountability and patient-centeredness: a framework that rewards low costs may discourage providers from offering expensive but necessary treatments. Finally, critics worry that Value-Based Care could widen disparities if providers avoid high-risk patients or if quality measures do not capture equity. These debates are not new; they echo earlier tensions between Managed Care’s cost focus and CCM’s clinical redesign, between IDS’s organizational logic and PCMH’s practice-level transformation. The frameworks of the past continue to shape the questions we ask today.